Abstract
Physicians have long recognized, though incompletely understood, the respiratory symptoms their patients may manifest after receiving a blood product transfusion [1, 2]. Today, two distinct pulmonary transfusion reactions are recognized as the likely etiology. Although both share a similar clinical phenotype of pulmonary edema and hypoxemic respiratory insufficiency, each have different management schemes and preventative strategies [3–6]. One reaction, called transfusionrelated acute lung injury (TRALI) is a life-threatening complication marked by acute inflammation and injury to the pulmonary parenchyma and vasculature with resultant alveolar flooding. The second, transfusion-associated circulatory overload (TACO) results from the compensatory capacity of the cardiovascular system being overwhelmed by an increase in intravascular volume. This overloaded state manifests as respiratory distress from hydrostatic pulmonary edema.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tung CL, Bien WN, Ch’u YC, Wang SH, Ma WS (1937) Chin Med J 52: 479
Barnard RD (1951) Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. N Y State J Med 51: 2399–2402
Lin Y, Saw CL, Hannach B, Goldman M (2012) Transfusion-related acute lung injury prevention measures and their impact at Canadian Blood Services. Transfusion (in press)
Gajic O, Rana R, Winters JL, et al (2007) Transfusion-related acute lung injury in the critically ill, prospective nested case-control study. Am J Respir Crit Care Med 176: 886–891
Kleinman SH, Popovsky MA (2008) TRALI: Mechanisms, Management, and Prevention, 1st Ed edn. American Association of Blood Banks Press, Bethesda
Gresens CJ, Holland PV (2001) Blood Safety and Surveillance. Marcel Dekker Inc, New York
Napolitano LM, Kurek S, Luchette FA (2009) Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 37: 3124–3157
Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year 2010. Available at: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ ReportaProblem/TransfusionDonationFatalities/ucm254802.htm Accessed November 2011
SHOT Steering Group (2010) Serious Hazards of Transfusion Annual Report 2010 Summary Available at: http://www.shotuk.org/wp-content/uploads/2011/07/SHOT-2010-Summary1. pdf Accessed November 2011
Popovsky MA, Abel MD, Moore SB (1983) Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 128: 185–189
Kleinman S, Caulfield T, Chan P, et al (2004) Toward an understanding of transfusionrelated acute lung injury: statement of a consensus panel. Transfusion 44: 1774–1789
Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA (2002) Transfusionrelated acute lung injury: report of a clinical look-back investigation. JAMA 287: 1968–1971
Eder AF, Herron R, Strupp A, et al (2007) Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 47: 599–607
Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA (2005) Proceedings of a consensus conference: towards an understanding of TRALI. Transfus Med Rev 19: 2–31
Eder AF, Herron RM, Jr., Strupp A, et al (2010) Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006–2008). Transfusion 50: 1732–1742
Kleinman S, Grossman B, Kopko P (2010) A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States. Transfusion 50: 1312–1321
Brown CJ, Navarrete CV (2011) Clinical relevance of the HLA system in blood transfusion. Vox Sang 101: 93–105
Bux J, Sachs UJ (2007) The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 136: 788–799
Silliman CC, Moore EE, Kelher MR, Khan SY, Gellar L, Elzi DJ (2011) Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury. Transfusion 51: 2549–2554
Kopko PM, Paglieroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV (2003) TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion 43: 177–184
Silliman CC (2006) The two-event model of transfusion-related acute lung injury. Crit Care Med 34 (5 Suppl): S124–131
Kor DJ, Van Buskirk CM, Gajic O (2009) Red blood cell storage lesion. Bosn J Basic Med Sci 9 (Suppl 1): 21–27
Popovsky MA, Moore SB (1985) Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 25: 573–577
Gajic O, Moore SB (2005) Transfusion-related acute lung injury. Mayo Clin Proc 80: 766–770
The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342: 1301–1308
Briel M, Meade M, Mercat A, et al (2010) Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 303: 865–873
Jawa RS, Anillo S, Kulaylat MN (2008) Transfusion-related acute lung injury. J Intensive Care Med 23: 109–121
Wiedemann HP, Wheeler AP, Bernard GR, et al (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354: 2564–2575
Steinberg KP, Hudson LD, Goodman RB, et al (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354: 1671–1684
Meduri GU, Headley AS, Golden E, et al (1998) Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 280: 159–165
Weigelt JA, Norcross JF, Borman KR, Snyder WH 3rd (1985) Early steroid therapy for respiratory failure. Arch Surg 120: 536–540
Jacobson JR, Barnard JW, Grigoryev DN, Ma SF, Tuder RM, Garcia JG (2005) Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 288: L1026–1032
Kor DJ, Iscimen R, Yilmaz M, Brown MJ, Brown DR, Gajic O (2009) Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury. Intensive Care Med 35: 1039–1046
O’Neal HRJ, Koyama T, Koehler EAS (2011) Prehospital statin and aspirin use and the prevalence of severe sepsis and acute lung injury/acute respiratory distress syndrome. Crit Care Med 39: 1343–1350
Su L, Kamel H (2007) How do we investigate and manage donors associated with a suspected case of transfusion-related acute lung injury. Transfusion 47: 1118–1124
Hébert PC, Wells G, Blajchman MA (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators. N Engl J Med 340: 409–417
Wilson K, MacDougall L, Fergusson D, Graham I, Tinmouth A, Hebert PC (2002) The effectiveness of interventions to reduce physician’s levels of inappropriate transfusion: what can be learned from a systematic review of the literature. Transfusion 42: 1224–1229
Cameron B, Rock G, Olberg B, Neurath D (2007) Evaluation of platelet transfusion triggers in a tertiary-care hospital. Transfusion 47: 206–211
Blumberg N, Heal JM, Gettings KF, et al (2010) An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 50: 2738–2744
Watkins TR, Rubenfeld GD, Martin TR, et al (2008) Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Crit Care Med 36: 1493–1499
Silliman CC, Clay KL, Thurman GW, Johnson CA, Ambruso DR (1994) Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 124: 684–694
Koch CG, Li L, Sessler DI et al (2008) Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358: 1229–1239
Vamvakas EC, Blajchman MA (2010) Blood still kills: six strategies to further reduce allogenic blood transfusion-related mortality. Transfus Med Rev 24: 77–124
Silliman CC, Moore EE, Johnson JL, Gonzalez RJ, Biffl WL (2004) Transfusion of the injured patient: proceed with caution. Shock 21: 291–299
Biffl WL, Moore EE, Offner PJ, Ciesla DJ, Gonzalez RJ, Silliman CC (z) Plasma from aged stored red blood cells delays neutrophil apoptosis and primes for cytotoxicity: abrogation by poststorage washing but not prestorage leukoreduction. J Trauma 50: 426–431
Preston FE, Laidlaw ST, Sampson B, Kitchen S (2002) Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol 116: 619–624
Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM (2004) Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 181: 492–497
Roback JD, Combs MR, Grossman BJ, Hillyer CD (2008) Technical Manual 16th edn. American Association of Blood Banks, Bethesda
Narick C, Triulzi DJ, Yazer MH (2011) Transfusion-associated circulatory overload after plasma transfusion. Transfusion (in press)
Li G, Rachmale S, Kojicic M (2011) Incidence and transfusion risk factors for transfusionassociated circulatory overload among medical intensive care unit patients. Transfusion 51: 338–343
Audet AM, Andrzejewski C, Popovsky MA (1998) Red blood cell transfusion practices in patients undergoing orthopedic surgery: a multi-institutional analysis. Orthopedics 21: 851–858
Rana RM, Rana SM, Fernandez ERM, Khan SAM, Gajic OM (2005) Transfusion related pulmonary edema in the intensive care unit (ICU). Chest 128 (Suppl):130s (abst)
Popovsky MA (2010) The Emily Cooley Lecture 2009: To breathe or not to breathe — that is the question. Pulmonary consequences of transfusion. Transfusion 50: 2057–2062
Finlay HE, Cassoria L, Feiner J, Toy P (2005) Designing and testing a computer-based screening system for transfusion-related acute lung injury. Am J Clin Path 124: 601–609
David B (2002) Haemovigilance: A comparison of three national systems. Proceedings of the 27th Congress of the International Society of Blood Transfusion: August 24-29th 2002, Vancouver (abst)
Li GM, Kojicic MM, Reriani MKM, et al (2010) Long-term survival & quality of life after transfusion-associated pulmonary edema in critically ill medical patients. Chest 137: 783–789
Whitaker BI. Reporting TACO and TRALI: Using the New National Hemovigilance Protocol to Categorize Transfusion Adverse Reactions. Available at: http://www.aabb.org/programs/ biovigilance/us/Documents/reportingtralitaco.pdf Accessed November 2011
Center for Disease Control (2010) National Healthcare Safety Network Manual-Biovigilance Component Protocol. In: Transfusion Associated Circulatory Overload. Center for Disease Control, Altanta
Singel DJ, Stamler JS (2005) Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu Rev Physiol 67: 99–145
Celis R, Torre-Martinez G, Torre-Amione G (2008) Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy? Curr Opin Cardiol 3: 254–260
Robillard P, Itaj NK, Chapdelaine A (2008) Increasing incidence of transfusion-associated circulatory overload reported to the Quebec Hemovigilance System 2000–2006. Transfusion 48:204A (abst)
Nieminen MS, Bohm M, Cowie MR, et al (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure — The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26: 384–416
Jessup M, Abraham WT, Casey DE, et al (2009) 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation 119: 1977–2016
Winck JC, Azevedo LF, Costa-Pereira A, Antonelli M, Wyatt JC (2006) Efficacy and safety of non-invasive ventilation in the treatment of acute cardiogenic pulmonary edema—a systematic review and meta-analysis. Crit Care 10:R69
Popovsky MA (2007) Transfusion Reactions, 3rd edn. AABB Press, Bethesda
Skeate RC, Eastlund T (2007) Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Curr Opin Haematol 14: 682–687
Wheeler AP, Bernard GR, Thompson BT et al (2006) Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. N Engl J Med 354: 2213–2224
Ely EW, Smith AC, Chiles C, et al (2001) Radiologic determination of intravascular volume status using portable, digital chest radiography: a prospective investigation in 100 patients. Crit Care Med 8: 1502–1512
Maisel AS, Krishnaswamy P, Nowak RM et al (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 347(3):161–167.
Zhou I, Giacherio D, Cooling L, Davenport RD (2005) Use of B-natriuretic peptide as a diagnostic marker of the differential diagnosis of transfusion-associated circulatory overload. Transfusion 45: 1056–1063
Tobain AAR (2008) N-Terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion 48: 1143–1150.
Li G, Daniels CE, Kojicic M (2009) The accuracy of naturietic peptides (brain naturietic peptids and N-terminal pro-brain naturietic) in differentiation between transfusionrelated acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion 49: 13–20
Rana R, Vlahakis NE, Daniels CE, et al (2006) B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema. Crit Care Med 34: 1941–1946
Gilliss BM, Looney MR (2011) Experimental models of transfusion-related acute lung injury. Transfus Med Rev 25: 1–11
Fadeyi EA, De Los Angeles Muniz M, Wayne AS, Klein HG, Leitman SF, Stroncek DF (2007) The transfusion of neutrophil-specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions. Transfusion 47: 545–550
Church GD, Price C, Sanchez R, Looney MR (2006) Transfusion-related acute lung injury in the paediatric patient: Two case reports and a review of the literature. Transfus Med 16: 343–348
Fein A, Grossman RF, Jones JG, et al (1979) The value of edema fluid protein measurement in patients with pulmonary edema. Am J Med 67: 32–38
Gajic O, Gropper MA, Hubmayr RD (2006) Pulmonary edema after transfusion: How to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit Care Med 34 (Suppl 5): s109–s113
Payne R (1962) The development and persistence of leukoagglutinins in parous women. Blood 19: 411–424
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Goldberg, A.D., Clifford, L., Kor, D.J. (2012). Transfusion-related Pulmonary Complications. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2012. Annual Update in Intensive Care and Emergency Medicine, vol 2012. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25716-2_41
Download citation
DOI: https://doi.org/10.1007/978-3-642-25716-2_41
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-25715-5
Online ISBN: 978-3-642-25716-2
eBook Packages: MedicineMedicine (R0)